drug-resistant epilepsy

1 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Bright Minds Biosciences Grants Stock Options as Healthcare Conference Appearance Looms

Bright Minds Biosciences to present at Jefferies Healthcare Conference in June 2026; grants 109,000 stock options at US$83.40 exercise price with four-year vesting.
DRUGserotonergic agonistsCNS disorders